Cargando…

A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines

Several countries have made unremitting efforts to develop an optimal vaccine in the fight against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing occurrence of SARS-CoV-2 variants, current vaccines show decreased neutra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Naru, Li, Kangchen, Liu, Zezhong, Nandakumar, Kutty Selva, Jiang, Shibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875727/ https://www.ncbi.nlm.nih.gov/pubmed/35215980 http://dx.doi.org/10.3390/v14020387

Ejemplares similares

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)

Current Progress in the Development of Zika Virus Vaccines
por: Zhou, Kehui, et al.
Publicado: (2021)

Polymer Chemistry Defines Adjuvant Properties and Determines the Immune Response against the Antigen or Vaccine
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Immunoengineered adjuvants for universal vaccines against respiratory viruses
por: Wang, Ji, et al.
Publicado: (2021)

Current development of COVID-19 diagnostics, vaccines and therapeutics
por: Zhang, Naru, et al.
Publicado: (2020)

Advancement in the Development of Therapeutics Against Zika Virus Infection
por: Li, Kangchen, et al.
Publicado: (2022)

Corrigendum: Advancement in the development of therapeutics against Zika virus infection
por: Li, Kangchen, et al.
Publicado: (2022)

Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
por: Zhang, Naru, et al.
Publicado: (2022)

Learning from the past: development of safe and effective COVID-19 vaccines
por: Su, Shan, et al.
Publicado: (2020)

A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
por: Wong, Kon Ken, et al.
Publicado: (2021)

Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective
por: Labouta, Hagar I., et al.
Publicado: (2022)

New Approaches to Vaccine Adjuvants: Inhibiting the Inhibitor
por: Graham, Barney S
Publicado: (2006)

ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?
por: Clemen, Ramona, et al.
Publicado: (2021)

Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
por: Nandakumar, Kutty Selva
Publicado: (2018)

Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad‐spectrum, and safe COVID‐19 vaccines and therapeutics
por: Su, Shan, et al.
Publicado: (2021)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness
por: Pogostin, Brett H., et al.
Publicado: (2021)

Tocotrienols are good adjuvants for developing cancer vaccines
por: Abdul Hafid, Sitti Rahma, et al.
Publicado: (2010)

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
por: Liu, Zezhong, et al.
Publicado: (2020)

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2006)

Editorial: Systemic lupus erythematosus - predisposition factors, pathogenesis, diagnosis, treatment and disease models
por: Nandakumar, Kutty Selva, et al.
Publicado: (2022)

Epicutaneous Application of Mannan Induces Psoriasis-like Inflammation in an Inbred Mouse Strain
por: Wu, Huimei, et al.
Publicado: (2023)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
por: Liu, Zezhong, et al.
Publicado: (2022)

COVID-19 vaccine equity: a health systems and policy perspective
por: Van De Pas, Remco, et al.
Publicado: (2021)

QS-21: A Potent Vaccine Adjuvant
por: Zhu, Daming, et al.
Publicado: (2015)

A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa
por: Dube, Admire, et al.
Publicado: (2021)

Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective
por: Khurana, Surender
Publicado: (2018)

Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity
por: Carlsen, Stefan, et al.
Publicado: (2006)

Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis
por: Fang, Qinghua, et al.
Publicado: (2020)

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis
por: Fang, Qinghua, et al.
Publicado: (2019)

Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines
por: Liu, Zezhong, et al.
Publicado: (2023)

Intranasal Vaccination Strategy to Control the COVID-19 Pandemic from a Veterinary Medicine Perspective
por: Annas, Salleh, et al.
Publicado: (2021)

Coronavirus disease 2019 vaccines: perspectives and update
por: Kaushik, S.K., et al.
Publicado: (2021)

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
por: Sempowski, Gregory D., et al.
Publicado: (2020)

TFDA takes actions to expedite the development of COVID-19 vaccines
por: Liu, Sam Chi-Hao, et al.
Publicado: (2022)

Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
por: Bok, Karin, et al.
Publicado: (2021)

The challenges of COVID‐19 Delta variant: Prevention and vaccine development
por: He, Xuemei, et al.
Publicado: (2021)

In-silico analysis of potent Mosquirix vaccine adjuvant leads
por: Onyango, Okello Harrison, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j5kdoijuc1h6j035sfjidcafrr